Clinical appropriateness of blood component transfusion: regulatory requirements and standards set by the Scientific Society in Italy

Por Grazzini, Giuliano
Publicado em 2008

Transfusion Medicine and Proteomics: an alliance for blood quality and safety

Por Grazzini, Giuliano
Publicado em 2010

Red blood cell storage lesion and adverse clinical outcomes: post hoc ergo propter hoc?

Por Grazzini, Giuliano, Vaglio, Stefania
Publicado em 2012

Alternative Blood Products and Clinical Needs in Transfusion Medicine

Por Whitsett, Carolyn, Vaglio, Stefania, Grazzini, Giuliano
Publicado em 2012

Plasma-derived medicinal products: demand and clinical use

Por Grazzini, Giuliano, Mannucci, Pier Mannuccio, Oleari, Fabrizio
Publicado em 2013

Tuscan Study on the Appropriateness of Fresh-frozen Plasma Transfusion (TuSAPlaT)

Por Liumbruno, Giancarlo Maria, Sodini, Maria Laura, Grazzini, Giuliano
Publicado em 2007

Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma

Por Liumbruno, Giancarlo Maria, Sodini, Maria Laura, Grazzini, Giuliano
Publicado em 2008

Ex Vivo Generated Red Cells as Transfusion Products

Por Migliaccio, Anna Rita, Grazzini, Giuliano, Hillyer, Christopher D.
Publicado em 2012

Could the different performance of the Procleix West Nile virus assay towards WNV L1 and L2 represent an issue in the blood transfusion setting?

Por Pisani, Giulio, Cristiano, Karen, Pupella, Simonetta, Grazzini, Giuliano
Publicado em 2014

Red blood cell storage: the story so far

Por D’Alessandro, Angelo, Liumbruno, Giancarlo, Grazzini, Giuliano, Zolla, Lello
Publicado em 2010

Patient Blood Management in Italy

Por Guerra, Ranieri, Velati, Claudio, Liumbruno, Giancarlo M., Grazzini, Giuliano
Publicado no Blood Transfus (2016)

West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008–2012 and their impact on blood safety

Por Pupella, Simonetta, Pisani, Giulio, Cristiano, Karen, Catalano, Liviana, Grazzini, Giuliano
Publicado em 2013

Public expenditure for plasma-derived and recombinant medicinal products in Italy

Por Lanzoni, Monica, Candura, Fabio, Calizzani, Gabriele, Biffoli, Claudia, Grazzini, Giuliano
Publicado em 2013

Intravenous iron and safety: is the end of the debate on the horizon?

Por Muñoz, Manuel, Gómez-Ramírez, Susana, Liumbruno, Giancarlo M., Grazzini, Giuliano
Publicado em 2014

Update on West Nile virus in Italy

Por Pupella, Simonetta, Pisani, Giulio, Cristiano, Karen, Catalano, Liviana, Grazzini, Giuliano
Publicado em 2014

Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components

Por Liumbruno, Giancarlo Maria, Catalano, Liviana, Piccinini, Vanessa, Pupella, Simonetta, Grazzini, Giuliano
Publicado em 2009

Comparison among plasma-derived clotting Factor VIII by using monodimensional gel electrophoresis and mass spectrometry

Por Timperio, Anna Maria, Gevi, Federica, Grazzini, Giuliano, Vaglio, Stefania, Zolla, Lello
Publicado em 2010

Zika virus and the never-ending story of emerging pathogens and Transfusion Medicine

Por Marano, Giuseppe, Pupella, Simonetta, Vaglio, Stefania, Liumbruno, Giancarlo M., Grazzini, Giuliano
Publicado no Blood Transfus (2016)

Changing blood donor screening criteria from permanent deferral for men who have sex with men to individual sexual risk assessment: no evidence of a significant impact on the human...

Por Suligoi, Barbara, Pupella, Simonetta, Regine, Vincenza, Raimondo, Mariangela, Velati, Claudio, Grazzini, Giuliano
Publicado em 2013

Plasma-derived medicinal products in Italy: information sources and flows

Por Lanzoni, Monica, Biffoli, Claudia, Candura, Fabio, Calizzani, Gabriele, Vaglio, Stefania, Grazzini, Giuliano
Publicado em 2013